Shay Capital’s Vincerx Pharma, Inc. Common Stock VINC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-568
Closed -$148K 735
2021
Q2
$148K Buy
+568
New +$173K 0.02% 437

Other funds holding VINC

Shay Capital's VINC Position: Q3 2021 in Review

Shay Capital sold out of Vincerx Pharma, Inc. Common Stock (VINC) in Q3 2021, closing a stake of 568 shares — an estimated $148K sold.

Shay Capital first reported a position in VINC in Q2 2021 and held it in 1 quarter. The position peaked at $148K in Q2 2021. 56 funds tracked by Wall St. Rank hold VINC as of Q3 2021.

  • Shay Capital reported no remaining Vincerx Pharma, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Shay Capital sold 568 Vincerx Pharma, Inc. Common Stock shares in Q3 2021, an estimated $148K.
  • Shay Capital first reported a position in Vincerx Pharma, Inc. Common Stock in Q2 2021 and held it in 1 quarter.
  • Shay Capital's Vincerx Pharma, Inc. Common Stock position peaked at $148K in Q2 2021.
  • 56 funds tracked by Wall St. Rank held Vincerx Pharma, Inc. Common Stock as of Q3 2021.

Based on Shay Capital's 13F filing for Q3 2021, filed 15 Nov 2021.